BioMark Diagnostics Inc. (BMKDF)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -1.31 Million CAD | 24.04% |
| 2023 | -1.73 Million CAD | -23.44% |
| 2022 | -1.4 Million CAD | -29.61% |
| 2021 | -1.08 Million CAD | 9.99% |
| 2020 | -1.2 Million CAD | -120.43% |
| 2019 | -545.61 Thousand CAD | 24.92% |
| 2018 | -726.74 Thousand CAD | -0.8% |
| 2017 | -721 Thousand CAD | 48.78% |
| 2016 | -1.4 Million CAD | 51.2% |
| 2015 | -2.88 Million CAD | -1493.6% |
| 2014 | -180.99 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -434.36 Thousand CAD | 7.94% |
| 2024 Q2 | -434.29 Thousand CAD | 0.02% |
| 2024 Q3 | -440.81 Thousand CAD | -1.5% |
| 2024 FY | -1.8 Million CAD | -4.31% |
| 2024 Q4 | -497.24 Thousand CAD | -12.8% |
| 2023 Q1 | -390.88 Thousand CAD | 43.59% |
| 2023 Q4 | -471.81 Thousand CAD | -27.03% |
| 2023 Q2 | -497.87 Thousand CAD | -27.37% |
| 2023 Q3 | -371.41 Thousand CAD | 25.4% |
| 2023 FY | -1.73 Million CAD | -23.44% |
| 2022 FY | -1.4 Million CAD | -29.61% |
| 2022 Q4 | -693 Thousand CAD | -181.07% |
| 2022 Q3 | -246.55 Thousand CAD | -38.58% |
| 2022 Q2 | -177.92 Thousand CAD | 37.71% |
| 2022 Q1 | -285.62 Thousand CAD | 49.64% |
| 2021 Q4 | -567.14 Thousand CAD | -192.06% |
| 2021 FY | -1.08 Million CAD | 9.99% |
| 2021 Q1 | -133.8 Thousand CAD | 52.16% |
| 2021 Q3 | -194.18 Thousand CAD | -3.59% |
| 2021 Q2 | -187.45 Thousand CAD | -40.1% |
| 2020 Q1 | -120.55 Thousand CAD | 2.16% |
| 2020 Q4 | -279.67 Thousand CAD | 58.44% |
| 2020 Q2 | -135.92 Thousand CAD | -12.75% |
| 2020 FY | -1.2 Million CAD | -120.43% |
| 2020 Q3 | -672.89 Thousand CAD | -395.04% |
| 2019 Q3 | -168.66 Thousand CAD | -5.05% |
| 2019 FY | -545.61 Thousand CAD | 24.92% |
| 2019 Q4 | -123.21 Thousand CAD | 26.95% |
| 2019 Q2 | -160.55 Thousand CAD | -44.76% |
| 2019 Q1 | -110.91 Thousand CAD | 21.83% |
| 2018 Q2 | -218.42 Thousand CAD | -14.92% |
| 2018 Q3 | -176.37 Thousand CAD | 19.25% |
| 2018 Q4 | -141.88 Thousand CAD | 19.56% |
| 2018 FY | -726.74 Thousand CAD | -0.8% |
| 2018 Q1 | -190.06 Thousand CAD | 21.91% |
| 2017 Q3 | -111.75 Thousand CAD | 25.65% |
| 2017 FY | -721 Thousand CAD | 48.78% |
| 2017 Q4 | -243.4 Thousand CAD | -117.8% |
| 2017 Q2 | -150.3 Thousand CAD | 30.26% |
| 2017 Q1 | -215.53 Thousand CAD | 69.43% |
| 2016 Q3 | -260.89 Thousand CAD | -12.36% |
| 2016 Q2 | -232.18 Thousand CAD | -10.94% |
| 2016 Q1 | -209.29 Thousand CAD | 70.74% |
| 2016 Q4 | -705.15 Thousand CAD | -170.29% |
| 2016 FY | -1.4 Million CAD | 51.2% |
| 2015 Q1 | -65.99 Thousand CAD | 0.0% |
| 2015 Q2 | -51.4 Thousand CAD | 22.11% |
| 2015 Q3 | -2.05 Million CAD | -3889.1% |
| 2015 Q4 | -715.31 Thousand CAD | 65.12% |
| 2015 FY | -2.88 Million CAD | -1493.6% |
| 2014 FY | -180.99 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -5.932% |
| Arrayit Corporation | -3.62 Million USD | 63.681% |
| Atlantic International Corp. | -5.73 Million USD | 77.049% |
| Biocept, Inc. | -31.98 Million USD | 95.886% |
| Bioqual, Inc. | -19.63 Thousand USD | -6599.649% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -70.393% |
| DermTech, Inc. | -103.73 Million USD | 98.732% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.053% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 93.684% |
| iMD Companies, Inc. | -175.44 Thousand USD | -649.904% |
| IDenta Corp. | -1499.00 USD | -87670.314% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 146.921% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 3500.561% |
| InVitro International | -25.33 Thousand USD | -5092.3% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 81.527% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -2164.037% |
| Medical Imaging Corp. | -819.48 Thousand USD | -60.55% |
| NovelStem International Corp. | -3.52 Million USD | 62.684% |
| Optigenex Inc. | 1.39 Million USD | 194.596% |
| PharmChem, Inc. | 973.14 Thousand USD | 235.198% |
| Proteome Sciences plc | -1.62 Million USD | 18.835% |
| Response Genetics, Inc | -21.37 Million USD | 93.845% |
| Rennova Health, Inc. | -1.4 Million USD | 6.659% |
| RushNet, Inc. | -684.7 Thousand USD | -92.152% |
| ScreenPro Security Inc. | -2.59 Million USD | 49.249% |
| Stella Diagnostics Inc. | -11.42 Million USD | 88.486% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 83.016% |
| Todos Medical Ltd. | -9.74 Million USD | 86.503% |